eHealth, Inc. Files 10-Q for Period Ending March 31, 2024

TL;DR

<b>eHealth, Inc. filed its Q1 2024 10-Q report on May 7, 2024.</b>

AI Summary

eHealth, Inc. (EHTH) filed a Quarterly Report (10-Q) with the SEC on May 7, 2024. eHealth, Inc. filed a 10-Q report for the period ending March 31, 2024. The filing covers the first quarter of 2024. The company's fiscal year ends on December 31st. eHealth, Inc. is incorporated in Delaware. The company's business and mailing address is in Austin, TX.

Why It Matters

For investors and stakeholders tracking eHealth, Inc., this filing contains several important signals. This filing provides an update on the company's financial performance and operational status for the first quarter of 2024. Investors and analysts can use this report to assess the company's current financial health and future prospects.

Risk Assessment

Risk Level: low — eHealth, Inc. shows low risk based on this filing. The filing is a standard quarterly report (10-Q) and does not contain immediate, significant new information that would drastically alter the company's risk profile.

Analyst Insight

Monitor future filings for detailed financial results and management commentary on performance trends.

Key Numbers

• 2024-03-31 — Period of Report (Quarterly filing date)
• 2024-05-07 — Filed As Of Date (Date of filing)
• 2023-12-31 — Prior Period End (Previous fiscal year end)

Key Players & Entities

• eHealth, Inc. (company) — Filer name
• 2024-03-31 (date) — Period of report
• 2024-05-07 (date) — Filed as of date
• Austin, TX (location) — Business address
• 737-248-2340 (phone) — Business phone
• DE (state) — State of incorporation
• 1231 (date) — Fiscal year end

FAQ

Industry Context

eHealth, Inc. operates in the insurance brokerage sector, specifically focusing on online health insurance sales.

Regulatory Implications

The company is subject to various regulations governing insurance sales and consumer protection, typical for the health insurance marketplace.

What Investors Should Do

1. Review the full 10-Q filing for detailed financial statements and management discussion.
2. Analyze any specific segment performance or risk factors mentioned in the report.
3. Compare Q1 2024 results with prior periods to identify trends.

Key Dates

• 2024-05-07: 10-Q Filing — Report for the quarter ended March 31, 2024

Year-Over-Year Comparison

This is the initial 10-Q filing for the fiscal year 2024, following the 2023 annual report.

Key Financial Figures

• $0.001 — ich registered Common Stock, par value $0.001 per share EHTH The Nasdaq Stock Market

Filing Documents

• ehth-20240331.htm (10-Q) — 1631KB
• a2024q1ex311.htm (EX-31.1) — 10KB
• a2024q1ex312.htm (EX-31.2) — 10KB
• a2024q1ex321.htm (EX-32.1) — 6KB
• a2024q1ex322.htm (EX-32.2) — 6KB
• 0001333493-24-000074.txt (&nbsp;) — 7615KB
• ehth-20240331.xsd (EX-101.SCH) — 57KB
• ehth-20240331_cal.xml (EX-101.CAL) — 92KB
• ehth-20240331_def.xml (EX-101.DEF) — 220KB
• ehth-20240331_lab.xml (EX-101.LAB) — 641KB
• ehth-20240331_pre.xml (EX-101.PRE) — 438KB
• ehth-20240331_htm.xml (XML) — 1058KB

FINANCIAL INFORMATION PAGE

PART I FINANCIAL INFORMATION PAGE

Financial Statements (Unaudited)

Item 1. Financial Statements (Unaudited) 2 Condensed Consolidated Balance Sheets 2 Condensed Consolidated Statements of Comprehensive Loss 3 Condensed Consolidated Statements of Stockholders' Equity 4 Condensed Consolidated Statements of Cash Flows 5 Notes to Condensed Consolidated Financial Statements 6

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 26

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk 45

Controls and Procedures

Item 4. Controls and Procedures 46 PART II OTHER INFORMATION

Legal Proceedings

Item 1. Legal Proceedings 47

Risk Factors

Item 1A. Risk Factors 47

Other Information

Item 5. Other Information 75

Exhibits

Item 6. Exhibits 75

Signatures

Signatures 76 1 Table of Contents

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS EHEALTH, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands, unaudited) March 31, 2024 December 31, 2023 Assets Current assets: Cash and cash equivalents $ 174,986 $ 115,722 Short-term marketable securities 13,946 5,930 Accounts receivable 1,407 3,993 Contract assets – commissions receivable – current 203,013 244,663 Prepaid expenses and other current assets 11,006 12,044 Total current assets 404,358 382,352 Contract assets – commissions receivable – non-current 642,320 673,514 Property and equipment, net 4,228 4,864 Operating lease right-of-use assets 16,268 22,767 Restricted cash 3,090 3,090 Other assets 25,374 26,758 Total assets $ 1,095,638 $ 1,113,345 Liabilities, convertible preferred stock and stockholders' equity Current liabilities: Accounts payable $ 6,287 $ 7,197 Accrued compensation and benefits 40,932 40,800 Accrued marketing expenses 9,404 20,340 Short term debt 68,196 — Lease liabilities – current 7,206 7,070 Other current liabilities 14,019 3,131 Total current liabilities 146,044 78,538 Long-term debt — 67,754 Deferred income taxes – non-current 28,305 29,687 Lease liabilities – non-current 26,285 28,333 Other non-current liabilities 4,789 4,949 Total liabilities 205,423 209,261 Commitments and contingencies (Note 8) Convertible preferred stock 307,410 298,053 Stockholders' equity: Common stock 42 41 Additional paid-in capital 803,248 798,786 Treasury stock, at cost ( 199,998 ) ( 199,998 ) Retained earnings (accumulated deficit) ( 20,427 ) 7,284 Accumulated other comprehensive loss ( 60 ) ( 82 ) Total stockholders' equity 582,805 606,031 Total liabilities, convertible preferred stock and stockholders' equity $ 1,095,638 $ 1,113,345 The accompanying notes are an integral part of these condensed consolidated financial statements. 2 Table of Contents EHEALTH, INC. CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (in thousands, except per share amounts, un

View Full Filing

View this 10-Q filing on SEC EDGAR